Orthofix Medical (OFIX) vs Profound Medical (PROF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Profound Medical (PROF) has outperformed Orthofix Medical (OFIX) over the past year, gaining 6.2% versus a loss of 60.2%. Over five years, PROF leads with a -43.6% price change compared with -80.6% for OFIX. Orthofix Medical is the larger company by market cap ($247.4 million vs $233.7 million), about 1.1 times the size, while Profound Medical is growing revenue faster (+50.7% vs +2.9%).
Orthofix Medical converts more of its revenue into profit, with a net margin of -11.2% versus -264.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OFIX | PROF |
|---|---|---|
| Share price | $6.07 | $6.38 |
| Market cap | $247.41M | $233.68M |
| 1-day change | -4.26% | -3.19% |
| YTD return | -59.96% | -18.93% |
| 1-year return | -60.22% | +6.16% |
| 5-year return | -80.64% | -43.64% |
| Forward P/E | 33.72 | — |
| EPS (TTM) | $-1.10 | $-0.94 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $822.31M | $16.10M |
| Revenue growth (YoY) | +2.85% | +50.73% |
| Net income (latest FY) | $-92.19M | $-42.57M |
| Gross margin | 68.83% | 70.77% |
| Operating margin | -9.90% | -256.27% |
| Net margin | -11.21% | -264.44% |
| 52-week high | $16.42 | $8.95 |
| 52-week low | $6.04 | $4.80 |
| Distance from 52-week high | -63.03% | -28.72% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +64.74% | +74.61% |
| Average volume | 481.16K | 208.29K |
| Shares outstanding | 40.76M | 36.63M |
| Employees | 1,605 | 162 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PROF has outperformed OFIX by 66.4 percentage points over the past year.
- Orthofix Medical is more profitable, keeping -11.2 cents of every revenue dollar as net income versus -264.4 cents for Profound Medical.
- Profound Medical grew revenue faster in its latest fiscal year (+50.73% vs +2.85%).
About Orthofix Medical
OFIX stock →Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.
Health Care · Medical/Dental Instruments · 1,605 employees
About Profound Medical
PROF stock →Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
Health Care · Medical/Dental Instruments · 162 employees
OFIX vs PROF FAQ
Which is bigger, Orthofix Medical or Profound Medical?
Orthofix Medical (OFIX) is larger, with a market capitalization of $247.41M compared with $233.68M for Profound Medical (PROF).
Which stock has performed better over the past year, OFIX or PROF?
PROF returned +6.16% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.
Are Orthofix Medical and Profound Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.